<SEC-DOCUMENT>0001192482-21-000487.txt : 20210604
<SEC-HEADER>0001192482-21-000487.hdr.sgml : 20210604
<ACCEPTANCE-DATETIME>20210604164901
ACCESSION NUMBER:		0001192482-21-000487
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20210602
FILED AS OF DATE:		20210604
DATE AS OF CHANGE:		20210604

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Nosenzo John
		CENTRAL INDEX KEY:			0001835973

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39130
		FILM NUMBER:		21997097

	MAIL ADDRESS:	
		STREET 1:		C/O BIOVENTUS INC.
		STREET 2:		4721 EMPEROR BOULEVARD, SUITE 400
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27703

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TELA Bio, Inc.
		CENTRAL INDEX KEY:			0001561921
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				455320061
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1 GREAT VALLEY PARKWAY, SUITE 24
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355
		BUSINESS PHONE:		484-320-2930

	MAIL ADDRESS:	
		STREET 1:		1 GREAT VALLEY PARKWAY, SUITE 24
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>edgar.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2021-06-02</periodOfReport>

    <noSecuritiesOwned>1</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001561921</issuerCik>
        <issuerName>TELA Bio, Inc.</issuerName>
        <issuerTradingSymbol>TELA</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001835973</rptOwnerCik>
            <rptOwnerName>Nosenzo John</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O TELA BIO, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>1 GREAT VALLEY PARKWAY, SUITE 24</rptOwnerStreet2>
            <rptOwnerCity>MALVERN</rptOwnerCity>
            <rptOwnerState>PA</rptOwnerState>
            <rptOwnerZipCode>19355</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable></nonDerivativeTable>

    <derivativeTable></derivativeTable>

    <remarks>No securities are beneficially owned.</remarks>

    <ownerSignature>
        <signatureName>/s/ Megan Smeykal as attorney-in-fact for John E. Nosenzo</signatureName>
        <signatureDate>2021-06-04</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>attachment_1.htm
<DESCRIPTION>POA
<TEXT>
<html><body><pre>                                POWER OF ATTORNEY



 Know all by these presents, that the undersigned hereby constitutes

and appoints the Chief Executive Officer, the Chief Financial Officer and the

Vice President-Financial Reporting of TELA Bio, Inc. (the &quot;Company&quot;), each as

the undersigned&#39;s true and lawful attorney-in-fact to:



 (1) execute for and on behalf of the undersigned, in the undersigned&#39;s

capacity as an officer and/or director of the Company, Forms 3, 4 and 5, in

accordance with Section 16(a) of the Securities Exchange Act of 1934 and the

rules thereunder;



 (2) do and perform any and all acts for and on behalf of the

undersigned which may be necessary or desirable to  (A)complete and execute

any such Form 3, 4, or 5, complete and execute any amendment or amendments

thereto, and  (C) timely file such form with the United States Securities

and Exchange Commission and any stock exchange or similar authority; and



 (3) take any other action of any type whatsoever in connection with

the foregoing which, in the opinion of such attorney-in-fact, may be of benefit

to, in the best interest of, or legally required by, the undersigned, it being

understood that the documents executed by such attorney-in-fact on behalf of

the undersigned pursuant to this Power of Attorney shall be in such form and

shall contain such terms and conditions as such attorney-in-fact may approve

in such attorney-in-fact&#39;s discretion.



 The undersigned hereby grants to the attorneys-in-fact full power and

authority to do and perform any and every act and thing whatsoever requisite,

necessary or proper to be done in the exercise of any of the rights and powers

herein granted, as fully to all intents and purposes as the undersigned might

or could do if personally present with full power of substitution or revocation,

hereby ratifying and confirming all that such attorney-in-fact or such

attorney-in-fact&#39;s substitute or substitutes, shall lawfully do or cause to be

done by virtue of this power of attorney and the rights and powers herein

granted.



 The undersigned acknowledges that the foregoing attorney-in-fact, in

serving in such capacity at the request of the undersigned, is not assuming,

nor is the Company assuming, any of the undersigned&#39;s responsibilities to

comply with Section 16 of the Securities Exchange Act of 1934.



 This Power of Attorney shall remain in full force and effect until the

undersigned is no longer required to file Forms 3, 4, and 5 with respect to

the undersigned&#39;s holdings of and transactions in securities issued by the

Company, unless earlier revoked by the undersigned in a signed writing delivered

to the foregoing attorneys-in-fact.



 IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney

to be executed as of this 1st day of June, 2021.



     /s/John Nosenzo

     Name: John Nosenzo

     Title: Director



</pre></body></html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
